NuVasive, Inc. (NASDAQ:NUVA) Median Sales Estimate At $269.782


The EPS projection of NuVasive, Inc. (NASDAQ:NUVA) for quarter ended 2016-09-30 is $0.38. Last week, the EPS forecast was $0.38 against target of $0.38, a month earlier. Two months ago, this estimate was $0.38 versus forecast of $0.38 three months earlier, implying a deviation of 0%.

NuVasive, Inc. (NASDAQ:NUVA) stated that 18 days ago, its stock price was positively revised 5 times while negative revisions were 1.

In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.

EPS estimate downgrade for NuVasive, Inc. (NASDAQ:NUVA) in the preceding 30, 120, 60 and 90 days were 0, 6, 0, and 6, correspondingly.

Earnings Surprises

NuVasive, Inc. (NASDAQ:NUVA) EPS target for the quarter closed 1 was $0.38, based on 11 recommendations. As reported on 2016-04-26 the EPS was $0.32. The change was $0.05, implying a percentage deviation of 18.52%. The projections showed a standard deviation of 0.02.

Quarterly Sales Estimates

NuVasive, Inc. (NASDAQ:NUVA) yearly sales prediction for the fiscal 2017 stands at $269.782 and the median estimate is at $269.782. Almost 2 analysts issued sales target.

Highest sales target is $273.295 while the lowest target is $266.27 showing standard deviation of 4.967%.

As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.

Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.

A quarter ago, 2 hiked sales target and 2 reduced sales forecast. NuVasive, Inc. (NASDAQ:NUVA) announced that the deviation in forecast was -0.088%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 8 times, 1 visits today)